Lan X

The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, China; Guangdong Engineering Technology Research Center for Translational Medicine of Mental Disorders, Guangzhou, China.

2 preprints · 10 papers · ORCID

PreprintKetamine

Esketamine's Therapeutic Effect on Anhedonia: A Post-hoc of a Randomized Controlled Trial

Wu Q, Li W, Luo Z +11

Europe PMC2026
ArticleKetamine

Multiple peripheral inflammatory markers in adolescents with major depressive disorder treated with repeated esketamine infusions: results from a randomized controlled trial.

Lan X, Wu Z, Wang C +8

Europe PMC2026
ArticleKetamine

Transcriptional Signatures of Mitochondrial Metabolism Predict Esketamine-Induced rACC Structural Changes in Adolescent Major Depression.

Zhou Y, Li W, Lan X +16

Europe PMC2025
ArticleKetamine

Effects of Esketamine on Postoperative Delirium and Postoperative Cognitive Function in Elderly Gastrointestinal Tumor Patients with Preoperative Anxiety.

Zha J, Chen H, Sun Z +7

Europe PMC2025
ArticleKetamine

Validation and clinical application of the Chinese version of the rapid response scale.

Chen Z, Shen J, Chen Y +7

Europe PMC2025
PreprintKetamine

Validation and Clinical Application of the Chinese Version of Rapid Response Scale

Chen Z, Shen J, Chen Y +7

Europe PMC2025
ArticleKetamine

Comparison of the Antianhedonic Effects of Repeated-dose Intravenous Ketamine in Older and Younger Adults with Major Depressive Episode.

Zheng W, Gu L, Tan J +6

Europe PMC2025
ArticleKetamine

Effect of Esketamine on Postoperative Delirium in Patients Undergoing Cardiac Valve Replacement with Cardiopulmonary Bypass: A Randomized Controlled Trial.

Xiong X, Shao Y, Chen D +3

Europe PMC2024
ArticleKetamine

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial.

Lan X, Wang C, Zhang F +7

Europe PMC2023
ArticleKetamine

Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial.

Zhou Y, Lan X, Wang C +8

Europe PMC2024
ArticleKetamine

Efficacy of repeated intravenous esketamine in adolescents with anxious versus non-anxious depression.

Lan X, Wang C, Zhang F +8

Europe PMC2023
ArticleKetamine

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial.

Liu H, Lan X, Wang C +8

Europe PMC2022